[HTML][HTML] Advances in COVID-19 mRNA vaccine development

E Fang, X Liu, M Li, Z Zhang, L Song, B Zhu… - Signal transduction and …, 2022 - nature.com
To date, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …

Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety

MT Mascellino, F Di Timoteo… - Infection and drug …, 2021 - Taylor & Francis
This review takes into consideration the principal vaccines developed against the SARS-
CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of …

[HTML][HTML] Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting …

MM Hatmal, MAI Al-Hatamleh, AN Olaimat, M Hatmal… - Vaccines, 2021 - mdpi.com
Background: Since the coronavirus disease 2019 (COVID-19) was declared a pandemic,
there was no doubt that vaccination is the ideal protocol to tackle it. Within a year, a few …

SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

H Fathizadeh, S Afshar, MR Masoudi… - International Journal of …, 2021 - Elsevier
The world has been suffering from COVID-19 disease for more than a year, and it still has a
high mortality rate. In addition to the need to minimize transmission of the virus through non …

DNA vaccines for SARS-CoV-2: toward third-generation vaccination era

VP Chavda, R Pandya… - Expert Review of …, 2021 - Taylor & Francis
ABSTRACT Introduction: Coronavirus outbreak 2019 (COVID-19) has affected all the
corners of the globe and created chaos to human life. In order to put some control on the …

A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines

P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …

[HTML][HTML] Vaccine technologies and platforms for infectious diseases: Current progress, challenges, and opportunities

M Ghattas, G Dwivedi, M Lavertu, MG Alameh - Vaccines, 2021 - mdpi.com
Vaccination is a key component of public health policy with demonstrated cost-effective
benefits in protecting both human and animal populations. Vaccines can be manufactured …

[HTML][HTML] Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration

R Chen, Z Lan, J Ye, L Pang, Y Liu, W Wu… - Frontiers in …, 2021 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing major threat to global …

A brief review on DNA vaccines in the era of COVID-19

M Shafaati, M Saidijam, M Soleimani, F Hazrati… - Future …, 2022 - Taylor & Francis
This article provides a brief overview of DNA vaccines. First, the basic DNA vaccine design
strategies are described, then specific issues related to the industrial production of DNA …

Heterologous prime–boost strategies for COVID-19 vaccines

B Sapkota, B Saud, R Shrestha… - Journal of travel …, 2022 - academic.oup.com
Abstract Background/Objective Heterologous prime–boost doses of COVID-19 vaccines
('mix-and-match'approach) are being studied to test for the effectiveness of Oxford …